Association between glycated hemoglobin and cognitive impairment in older adults with coronary heart disease: a
Wen Zheng1, Qin-Jie Xin1, Xiao-Xia Wang2
1Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Insights
High glycated hemoglobin (HbA1c) levels are linked to cognitive impairment in older adults with coronary heart disease (CHD). This finding may enhance cognitive screening for at-risk patients.
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- The link between glycated hemoglobin (HbA1c) and cognitive impairment in older adults with coronary heart disease (CHD) is not well understood.
- Cognitive decline is a significant concern in aging populations, particularly those with cardiovascular conditions.
Purpose of the Study:
- To investigate the association between glycated hemoglobin (HbA1c) levels and cognitive impairment in elderly patients diagnosed with coronary heart disease (CHD).
- To determine if HbA1c is an independent risk factor for cognitive impairment in this demographic.
Main Methods:
- A prospective cohort study was conducted with 3244 participants aged 65 years and older in Beijing, China.
- Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).
- Serum HbA1c levels were measured, and participants were categorized into high (≥ 6.5 mmol/L) and low (< 6.5 mmol/L) HbA1c groups. Logistic regression analyses were employed.
Main Results:
- Elevated HbA1c levels were significantly associated with an increased risk of cognitive impairment in older adults with CHD.
- Logistic regression confirmed HbA1c as an independent risk factor, whether treated as a continuous or categorical variable (OR = 1.27, 95% CI: 1.15-1.40; OR = 1.79, 95% CI: 1.41-2.26).
- A linear relationship was observed between HbA1c levels and the risk of cognitive impairment (p for non-linear = 0.323).
Conclusions:
- Higher glycated hemoglobin (HbA1c) levels are associated with a greater risk of cognitive impairment in elderly patients with coronary heart disease (CHD).
- These findings suggest that monitoring HbA1c levels could aid in improving the accuracy and sensitivity of cognitive screening in this vulnerable population.
Background:
The relationship between glycated hemoglobin (HbA1c) and cognitive impairment in older adults with coronary heart disease (CHD) remains unclear.
Methods:
The present study used a prospective cohort study design and included 3244 participants aged ≥ 65 years in Beijing, China. The Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were used to assess cognitive function. Serum HbA1c was detected at admission. All patients were divided into high HbA1c group (≥ 6.5 mmol/L) and low HbA1c group (< 6.5 mmol/L) based on their HbA1c levels. Logistic regression analyses were used to evaluate the association between HbA1c and cognitive impairment.
Results:
In this study of 3244 participants, 1201 (37.0%) patients were in high HbA1c group and 2045 (63.0%) patients were in a state of cognitive impairment. Logistic regression analyses demonstrated that HbA1c was an independent risk factor for cognitive impairment regardless of whether the HbA1c was a continuous or categorical variable (OR = 1.27, 95% CI: 1.15-1.40, P < 0.001; OR = 1.79, 95% CI: 1.41-2.26, P ≤ 0.001, respectively). The restricted cubic spline curve exhibited that the relationship between the HbA1c and cognitive impairment was linear (p for non-linear = 0.323, P < 0.001).
Conclusion:
Elevated levels of HbA1c were associated with an increased risk of cognitive impairment in older patients with CHD. These insights could be used to improve the accuracy and sensitivity of cognitive screening in these patient populations.
More Related Videos
Related Concept Videos
Cognitive Development During Adulthood
Diabetes: Symptoms, Diagnosis, and Complications
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...


